Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Payne

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
BMC Health Services Research|April 24, 2025
"Our needs, our priorities, listen to us!" recommendations for improving HIV prevention and the cascade of care from people living with HIV in Manitoba, Canada: a qualitative studyEnrique Villacis-Alvarez, Margaret Haworth-Brockman, Katharina Maier, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
The Lancet. Infectious Diseases|May 9, 2022
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trialMoses Laman, Livingstone Tavul, Stephan Karl, et al.
Iscience|May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccinationJeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Disability and Rehabilitation|November 29, 2021
Developing a research agenda on exercise and physical activity for people with limb loss in CanadaCrystal MacKay, Leanna Lee, Krista Best, et al.
Tropical Medicine and Infectious Disease|December 27, 2024
Gender and Intersecting Barriers and Facilitators to Access the HIV Cascade of Care in Manitoba, Canada, Before and During the COVID-19 Pandemic: A Qualitative StudyEnrique Villacis-Alvarez, Cheryl Sobie, Katharina Maier, et al.
Vaccine|September 2, 2023
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccineHolly M Dudley, Megan O'Mara, Ann Auma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell CarcinomaNussara Pakvisal, Piriya Wongkongkathep, Worawan Bunrasmee, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
BMC Health Services Research|April 24, 2025
"Our needs, our priorities, listen to us!" recommendations for improving HIV prevention and the cascade of care from people living with HIV in Manitoba, Canada: a qualitative studyEnrique Villacis-Alvarez, Margaret Haworth-Brockman, Katharina Maier, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
The Lancet. Infectious Diseases|May 9, 2022
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trialMoses Laman, Livingstone Tavul, Stephan Karl, et al.
Iscience|May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccinationJeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Disability and Rehabilitation|November 29, 2021
Developing a research agenda on exercise and physical activity for people with limb loss in CanadaCrystal MacKay, Leanna Lee, Krista Best, et al.
Tropical Medicine and Infectious Disease|December 27, 2024
Gender and Intersecting Barriers and Facilitators to Access the HIV Cascade of Care in Manitoba, Canada, Before and During the COVID-19 Pandemic: A Qualitative StudyEnrique Villacis-Alvarez, Cheryl Sobie, Katharina Maier, et al.
Vaccine|September 2, 2023
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccineHolly M Dudley, Megan O'Mara, Ann Auma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell CarcinomaNussara Pakvisal, Piriya Wongkongkathep, Worawan Bunrasmee, et al.
Pageof 13